Intrinsic Value of S&P & Nasdaq Contact Us

Mettler-Toledo International Inc. MTD NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
65/100
4/7 Pass
SharesGrow Intrinsic Value
$884.10
-34.1%
Analyst Price Target
$1,499.17
+11.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Mettler-Toledo International Inc. (MTD) trades at a trailing P/E of 30.5, forward P/E of 28.9. Trailing earnings yield is 3.28%, forward earnings yield 3.47%. PEG 8.25.

Criteria proven by this page:

  • VALUE (33/100, Fail) — PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 8.25).
  • Forward P/E 28.9 (down from trailing 30.5) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 8.25 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 3.28% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 3.47% as earnings recover.
  • Analyst consensus target $1,499.17 (+11.8% upside) — modest upside expected.

Overall SharesGrow Score: 65/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
65/100
SG Score
View full scorecard →
VALUE
33/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
MOAT
76/100
→ Income
~
GROWTH
45/100
→ Income
INCOME
85/100
→ Income

Valuation Snapshot — MTD

Valuation Multiples
P/E (TTM)30.5
Forward P/E28.9
PEG Ratio8.25
Forward PEG2.80
P/B Ratio-1,122.81
P/S Ratio6.57
EV/EBITDA23.2
Per Share Data
EPS (TTM)$42.65
Forward EPS (Est.)$46.50
Book Value / Share$-1.16
Revenue / Share$197.56
FCF / Share$41.64
Yields & Fair Value
Earnings Yield3.28%
Forward Earnings Yield3.47%
Dividend Yield0.00%
SharesGrow IV$884.10 (-34.1%)
Analyst Target$1,499.17 (+11.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 28.9 2.12 25.52 4.43 -
2017 42.4 47.23 29.11 5.85 -
2018 27.8 0.71 24.17 4.86 -
2019 34.7 2.81 46.32 6.48 -
2020 45.2 4.30 96.29 8.82 -
2021 51.0 1.61 229.00 10.56 -
2022 37.3 2.24 1,311.29 8.29 -
2023 33.6 -4.84 -176.75 7.00 -
2024 30.1 2.38 -204.66 6.71 -
2025 33.1 8.96 -1,215.71 7.14 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $14.22 $2.51B $384.37M 15.3%
2017 $14.24 $2.73B $375.97M 13.8%
2018 $19.88 $2.94B $512.61M 17.5%
2019 $22.47 $3.01B $561.11M 18.6%
2020 $24.91 $3.09B $602.74M 19.5%
2021 $32.78 $3.72B $768.99M 20.7%
2022 $38.41 $3.92B $872.5M 22.3%
2023 $35.90 $3.79B $788.78M 20.8%
2024 $40.67 $3.87B $863.14M 22.3%
2025 $42.17 $4.03B $869.19M 21.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $46.50 $45.90 – $46.75 $4.23B $4.17B – $4.26B 8
2027 $51.09 $50.39 – $51.65 $4.44B $4.42B – $4.48B 8
2028 $56.93 $56.06 – $57.87 $4.68B $4.68B – $4.69B 3
2029 $62.62 $61.84 – $63.22 $4.92B $4.88B – $4.96B 1
2030 $68.32 $67.48 – $68.97 $5.09B $5.05B – $5.13B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message